elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Pricing
Log in
Sign up
Home
/
Subjects
/
Dyslipidemia
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Dyslipidemia
RIS
0.001
(Research Intensity Score)
Papers
64
Top papers
A review of the pathways of human exposure to poly- and perfluoroalkyl substances (PFASs) and present understanding of health effects
2018 · 2687 citations
Perfluoroalkyl/Polyfluoroalkyl Substances: Links to Cardiovascular Disease Risk
2024 · 95 citations
Major Global Coronary Artery Calcium Guidelines
2022 · 221 citations
Role of Chronic Kidney Disease (CKD)–Mineral and Bone Disorder (MBD) in the Pathogenesis of Cardiovascular Disease in CKD
2023 · 95 citations
A review of cardiovascular effects and underlying mechanisms of legacy and emerging per- and polyfluoroalkyl substances (PFAS)
2023 · 100 citations
Advances in kidney disease: pathogenesis and therapeutic targets
2025 · 28 citations
Iron Metabolism in Obesity and Metabolic Syndrome
2020 · 235 citations
Exposure to perfluoroalkyl substances (PFAS) and dyslipidemia, hypertension and obesity in adolescents. The Fit Futures study
2021 · 178 citations
The relationship between PFAS exposure and dyslipidemia: an updated review, meta-analysis, and evaluation of bias
2025 · 13 citations
Newest papers
Protection against diet-induced weight gain by a single-point mutation in Kir2.1 channels
2026
Sex-Specific Associations Between MTHFR, PPARG and ADRB3 Polymorphisms, Habitual Nutrient Intake and Metabolic Risk in Obesity: A Cross-Sectional Single-Centre Study
2026
Therapeutic apheresis: An effective strategy for a combined targeting of circulating lipoproteins, inflammatory markers, PFAS, and microplastics in cardiometabolic and neurodegenerative disease?
2026
Reconceptualizing Dyslipidemia: Diversity of Lipid Imbalances and Their Clinical Implications; A Narrative Review
2026
A multi-center, open-label, observational study to evaluate the efficacy and safety of LivaloZet® tablets in patients with dyslipidemia and metabolic syndrome: PIVOT study protocol
2026
Investigation of the Association Between Metabolic Biomarkers and Neurophysiological Findings in Idiopathic Sensorimotor Polyneuropathy
2026
Survodutide for Obesity in Chinese Adults: Phase 3 Randomized Trial Design and Baseline Characteristics (SYNCHRONIZE™-CN)
2026
Enhanced Therapeutic Efficacy of Lispro-Protamine Insulin Via Vanadate and Decavanadate Functionalization in a Type 1 Diabetes Murine Model
2026 · 1 citations
Early prediction of novel dynamic subphenotypes in acute pancreatitis with hypertriglyceridemia: a multicenter cohort study
2026
Browse all papers →
Dyslipidemia's history
Research intensity over time
Yearly
Personal members see monthly resolution →
Data temporarily unavailable — please try again shortly.
Close ✕
Dyslipidemia's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link